Showing results (1251-1260 of 2,915) with videos related to

Sort By:
Pageof 292
Cancer Gene Therapy|December 20, 2008
Nanoparticle delivery of anti-metastatic NM23-H1 gene improves chemotherapy in a mouse tumor modelZ Li, J Xiang, W Zhang, et al.
Cancer Gene Therapy|December 20, 2008
Transgene expression of alpha tumor necrosis factor with mutations D142N and A144R under control of human telomerase reverse transcriptase promoter eradicates well-established tumors and induces long-term antitumor immunityJ Xiang, M A Munegowda, Y Deng
Cancer Gene Therapy|March 17, 2009
Phase II trial of Belagenpumatucel-L, a TGF-beta2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patientsJ Nemunaitis, M Nemunaitis, N Senzer, et al.
Cancer Gene Therapy|June 6, 2009
Oncolytic adenovirus expressing interleukin-18 induces significant antitumor effects against melanoma in mice through inhibition of angiogenesisJ-N Zheng, D-S Pei, L-J Mao, et al.
Cancer Gene Therapy|June 23, 2009
Enhancement of antitumor activity of gammaretrovirus carrying IL-12 gene through genetic modification of envelope targeting HER2 receptor: a promising strategy for bladder cancer therapyY-S Tsai, A-L Shiau, Y-F Chen, et al.
Cancer Gene Therapy|June 27, 2009
Mutant mouse p53 transgene elevates the chemical induction of tumors that respond to gene silencing with siRNAH Tanooka, K Tatsumi, H Tsuji, et al.
Cancer Gene Therapy|October 11, 2008
Transcription factors: their potential as targets for an individualized therapeutic approach to cancerC Mees, J Nemunaitis, N Senzer
Cancer Gene Therapy|February 7, 2009
Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cellsB J Passer, P Castelo-Branco, J S Buhrman, et al.
Cancer Gene Therapy|November 25, 2010
Inhibition of cervical cancer cell growth in vitro and in vivo with dual shRNAsW Gu, E Payne, S Sun, et al.
Cancer Gene Therapy|November 2, 2010
TRAIL-transduced multipotent mesenchymal stromal cells (TRAIL-MSC) overcome TRAIL resistance in selected CRC cell lines in vitro and in vivoL P Mueller, J Luetzkendorf, M Widder, et al.
Pageof 292